Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

drug accessibility

- PMLiVE

GSK sales drop as austerity measures hit business in Europe

Revenues in region drop 9 per cent

Market access opportunities in China

Pope Woodhead highlights the key steps to accessing the high-value therapeutics market in China

EC pricing and reimbursement efficiency plans

The European Commission (EC) is working to help medicines reach the market quicker by streamlining the pricing and reimbursement process

- PMLiVE

Demonstrating value and improving access

In today’s dynamic healthcare market, it’s all about how we can demonstrate value and improve access – it is the art of effective communication and education that will enable success

- PMLiVE

Embracing the new paradigm in pharma market access

Pharma needs to change its image from being drug producers to healthcare provider partners

- PMLiVE

The journey to market access 5.0

Few in pharma are unaware of the importance of delivering demonstrable value in collaboration with payers. But are we serious about patient outcomes?

- PMLiVE

Market access webinar series begins with UK healthcare changes

Experts convene for first Sudler & Hennessey and Kantar Health online event

- PMLiVE

Proving value in uncertain times

Industry needs to be perceived as a contributor to healthcare solutions not just a cost

- PMLiVE

The role of systematic review in market access

Modern market access activities need to be evidence-based. But what does this really mean for new products being taken to market around the world? 

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links